Matthew David
2022
In 2022, Matthew David earned a total compensation of $1.1M as Executive Vice President and Chief Financial Officer at CorMedix, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $389,485 |
|---|---|
| Option Awards | $305,900 |
| Salary | $393,462 |
| Other | $47,697 |
| Total | $1,136,544 |
David received $393.5K in salary, accounting for 35% of the total pay in 2022.
David also received $389.5K in non-equity incentive plan, $305.9K in option awards and $47.7K in other compensation.
Rankings
In 2022, Matthew David's compensation ranked 2,740th out of 5,506 executives tracked by ExecPay. In other words, David earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,740 out of 5,506 | 50th |
Division Manufacturing | 1,520 out of 2,985 | 49th |
Major group Chemicals And Allied Products | 701 out of 1,340 | 48th |
Industry group Drugs | 653 out of 1,243 | 48th |
Industry Pharmaceutical Preparations | 469 out of 897 | 48th |
Source: SEC filing on September 13, 2023.
David's colleagues
We found four more compensation records of executives who worked with Matthew David at CorMedix in 2022.